
Frantz EyeCare reports 98% of Light Adjustable Lens patients achieved refractive accuracy within ±0.50 D of target, exceeding published national cataract surgery benchmarks.
Developments over the past year have benefited ophthalmologists with an improved ability to diagnose and manage glaucoma, while ongoing research focusing on new therapeutic targets and innovative modalities is providing hope for even better treatment tools in the future.




